Dosing typically begins at a lower dose, suggested initiation of 20 units (0.2 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 14: Inject 20 units (0.2 mL) one time per week Weeks 58: Inject 40 units (0.4 mL) one time per week Weeks 912: Inject 70 units (0.7 mL) one time per week Weeks 1316: Inject 90 units (0.9 mL) one time per week Weeks 1720: Inject 120 units (1.2 mL) one time per week Week 21+: Inject 140 units (1.4 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
Dosing Example: If your protocol calls for a 250mcg dose, you'd need to draw a very small amount
Gallbladder disease, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis), has been reported with GLP-1 receptor agonists as a class
Different forms of botulinum toxin solutions are used, depending on the problem being addressed
One important caveat: IGF-1 LR3 retains its ability to bind the insulin receptor (IR), forming hybrid IGF1R/IR complexes
Research suggests it influences growth factor expression, particularly VEGF and EGF, which play crucial roles in tissue regeneration
